Extracellular gadolinium-based contrast media: An overview
- 1 May 2008
- journal article
- review article
- Published by Elsevier in European Journal of Radiology
- Vol. 66 (2) , 160-167
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosisEuropean Radiology, 2007
- Gadolinium and nephrogenic systemic fibrosisKidney International, 2007
- Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?Acta Radiologica, 2007
- MR contrast agents: Physical and pharmacologic basicsJournal of Magnetic Resonance Imaging, 2007
- Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agentsCancer Imaging, 2007
- Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injectionsEuropean Radiology, 2006
- Gadolinium‐based contrast agents and nephrotoxicity in patients undergoing coronary artery proceduresCatheterization and Cardiovascular Interventions, 2006
- The safety of gadolinium in patients with stage 3 and 4 renal failureNephrology Dialysis Transplantation, 2005
- Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal x-ray attenuation in renal arteriography: An experimental study in pigs1Academic Radiology, 2004
- Safety of magnetic resonance imaging contrast agentsJournal of Magnetic Resonance Imaging, 1999